Lv1
80 积分 2023-02-18 加入
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
2小时前
待确认
Efficacy and safety of telitacicept in patients with class III–V lupus nephritis: A real-world retrospective cohort study
25天前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
1个月前
已完结
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
1个月前
已关闭
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
1个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
1个月前
已完结
Pulmonary Fibrosis in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
1个月前
已关闭
The pathogenesis and treatment in antineutrophil cytoplasmic antibody associate
1个月前
已完结
Retroperitoneal fibrosis as the presenting manifestation of IgG4-related disease in a patient previously diagnosed with granulomatosis with polyangiitis (Wegener’s): one disease or two?
2个月前
已完结
Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature
2个月前
已完结
皖公网安备34019202002308
